EPHA2 and osteosarcoma: In all EphA2-silenced osteosarcoma cell lines, we detected a significant reduction in cell viability compared to scrambled controls (p < 0.05 in HOS and KHOS/NP, p < 0.01 in U-2 OS and p < 0.001 in MNNG-HOS, Figure 4C).